Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for LBBB Prevention Post-TAVR
NCT06762145Phase 4Not yet recruiting
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone injection in Left bundle branch block (LBBB). Planned start Jan 2025; status: not yet recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
Left bundle branch block (LBBB)
Beyond the preview
Go deeper on NCT06762145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06762145.